• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    JanOne Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    5/6/24 4:59:24 PM ET
    $JAN
    Home Furnishings
    Consumer Discretionary
    Get the next $JAN alert in real time by email
    false 0000862861 0000862861 2024-05-06 2024-05-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

     

    FORM 8-K

     

     

     

    CURRENT REPORT

     

    PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): May 6, 2024

     

     

     

    JANONE INC.

    (Exact Name of Registrant as Specified in Charter)

     

     

     

    Nevada   000-19621   41-1454591

    (State or Other Jurisdiction

    of Incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    325 E. Warm Springs Road, Suite 102

    Las Vegas, NV 89119

    (Address of Principal Executive Offices and Zip Code)

     

    Registrant’s telephone number, including area code: 702-997-5968

    (Former Name or Former Address, if Changed Since Last Report)

     

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class  

    Trading Symbol(s)

      Name of each exchange on which registered
    Common Stock, $0.001 par value per share   JAN  

    The NASDAQ Stock Market LLC

    (The NASDAQ Capital Market)

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     
     

     

    Section 1 – Registrant’s Business and Operations

     

    Item 1.01 Entry into a Material Definitive Agreement.

     

    On May 1, 2024, JanOne Inc. (the “Company” or “our”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with two certain institutional investors (the “Investors”) for the sale by the Company in a registered direct offering priced at-the-market under the rules of The Nasdaq Stock Market (the “Offering”) of 79,782 units (the “Units”) of the Company’s securities, each Unit consisting of one share of our common stock, par value $0.001 per share (“Common Stock”), and one common stock purchase warrant for the purchase of an additional share of Common Stock (“Warrants”), at a purchase price of $3.775 per Unit. Each Warrant will be exercisable immediately following issuance at an exercise price of $3.63 per share and will have a term equal to three years from the closing of the offering. Neither investor is a “U.S. Person,” as such term is defined in Regulation S under the Securities Act of 1933, as amended (“Securities Act”) and each is an “accredited investor” as such term is defined in Rule 501(a) under the Securities Act.

     

    The aggregate gross proceeds from the Offering were approximately $300,000, before deducting related expenses. The Company intends to use the net proceeds for working capital and general corporate purposes. The Purchase Agreement contains customary representations, warranties and agreements by the Company and the Investors and customary indemnification rights and obligations of the parties.

     

    The closing of the Offering occurred on May 1, 2024. The Company did not use the services of a placement agent.

     

    The Units sold in the Offering were offered and sold by the Company pursuant to an effective shelf registration statement on Form S–3 (File No. 333-278784), which was initially filed with the Securities and Exchange Commission on April 18, 2024, and was declared effective on April 25, 2024. On May 6, 2024, the Company filed a prospectus supplement with the SEC in connection with the sale of the Units.

     

    The representations, warranties, and covenants contained in the Purchase Agreement were made solely for the benefit of the parties to the Purchase Agreement. In addition, such representations, warranties, and covenants (i) are intended as a way of allocating the risk between the parties to the Purchase Agreement and not as statements of fact and (ii) may apply standards of materiality in a way that is different from what may be viewed as material by stockholders of, or other investors in, the Company. Accordingly, the Purchase Agreement is included with this filing only to provide investors with information regarding the terms of the transaction, and not to provide investors with any other factual information regarding the Company. Stockholders should not rely on the representations, warranties, and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the Company or any of its subsidiaries or affiliates. Moreover, information concerning the subject matter of the representations and warranties may change after the date of the Purchase Agreement, which subsequent information may or may not be fully reflected in public disclosures.

     

    The foregoing descriptions of the Warrants and the Purchase Agreement are not complete and are qualified in their entirety by reference to the full text of such documents, copies of which are filed herewith as Exhibits 4.6 and 10.108 to this Current Report on Form 8-K and are incorporated by reference herein.

     

    This Current Report on Form 8-K does not constitute an offer to sell any securities or a solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

     

    A copy of the opinion of Clark Hill LLP relating to the legality of the issuance and sale of the Shares is attached as Exhibit 5.1 hereto.

     

    Section 9 – Financial Statements and Exhibits

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    Exhibit No.   Description
    4.6   Form of Warrant, dated May 1, 2024.
    5.1   Opinion of Clark Hill LLP.
    10.108   Form of Securities Purchase Agreement, dated May 1, 2024.
    23.1   Consent of Clark Hill LLP (included in Exhibit 5.1).
    23.2   Consent of Hudgens CPA, PLLC.
    23.3   Consent of Frazier & Deeter, LLC.
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

     
     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, we have duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      JanOne Inc.
         
      By: /s/ Tony Isaac
      Name: Tony Isaac
      Title: President and Chief Executive Officer

     

    Dated: May 6, 2024

     

     

     

     

    Get the next $JAN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $JAN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $JAN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ALT5 Sigma Corporation Partners With Hashtag Influencer to Enable Cryptocurrency Payment Processing for Influencer Marketing

      LAS VEGAS, NV / ACCESSWIRE / January 15, 2025 / ALT5 Sigma Corporation (NASDAQ:ALTS), a prominent innovator in the cryptocurrency sector, is pleased to announce a partnership with Hashtag Influencer, an advanced AI-powered SocialFi platform. This collaboration aims to enhance the influencer marketing landscape by enabling influencers in the gig economy to seamlessly and compliantly accept cryptocurrency payments for advertising deals with brands through social media platforms such as Instagram, Facebook, YouTube, and LinkedIn."While much attention has been given to the adoption of blockchain by traditional institutions, collaborating with innovators such as Hashtag Influencer-a forthcoming A

      1/15/25 7:00:00 AM ET
      $ALTS
      $JAN
      Home Furnishings
      Consumer Discretionary
    • Alyea Therapeutics to Present at Biotech Showcase 2025 During 43rd Annual J.P. Morgan Healthcare Conference Week

      Finalist to present at RESI JPM IPC and attend the Nasdaq Opening Bell Ceremony on January 13 LAS VEGAS, NV / ACCESSWIRE / January 10, 2025 / Alyea Therapeutics Corporation Inc. ("Alyea" or the "Company"), a subsidiary of Alt 5 Sigma Corporation (NASDAQ:ALTS), announced today its engagement in key events during the 43rd Annual J.P. Morgan Healthcare Conference Week, to be held on January 13-16, 2025, in San Francisco, California. Alyea is developing innovative, actionable solutions intended to help end the opioid crisis with its lead asset ("JAN123"), a novel formulation of Low Dose Naltrexone ("LDN"), preparing for its pivotal Phase III study. Having already been granted Orphan Drug designa

      1/10/25 8:30:00 AM ET
      $ALTS
      $JAN
      Home Furnishings
      Consumer Discretionary
    • ALT5 Sigma to Exhibit at iFX EXPO Dubai January 14-16, 2025

      LAS VEGAS, NV / ACCESSWIRE / January 9, 2025 / ALT5 Sigma Corporation (NASDAQ:ALTS), a fintech, providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, announced its participation in the upcoming iFX EXPO Dubai.ALT5 will be exhibiting through the three days of the show at the Dubai World Trade Centre, providing product demonstrations, solutions and general information to many of the 7,000+ attendees starting January 14th in booth #26.iFX EXPO Dubai 2025 is the ultimate meeting place for brokers, affiliates, traders, investors, and tech- and service-providers who are looking to succeed in the MENA

      1/9/25 11:30:00 AM ET
      $ALTS
      $JAN
      Home Furnishings
      Consumer Discretionary

    $JAN
    Leadership Updates

    Live Leadership Updates

    See more
    • ALT5 Sigma Welcomes FinTech Executive, Ron Pitters to Its Board of Directors

      LAS VEGAS, NV / ACCESSWIRE / November 6, 2024 / ALT5 Sigma Corporation (NASDAQ:ALTS) ("ALT5" or the "Company"), a fintech innovator providing next-generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and secure storage of digital assets, is pleased to announce the appointment of Mr. Ron Pitters to its Board of Directors."We are thrilled to welcome industry veteran, Ron Pitters, to our Board. With a unique blend of experience in both traditional finance and disruptive blockchain technologies, Ron brings invaluable insights. His proven track record, spanning from startups to multinational corporations, makes him a fantastic addition to our team,"

      11/6/24 8:30:00 AM ET
      $ALTS
      $JAN
      Home Furnishings
      Consumer Discretionary
    • JanOne Appoints Vay Tham as its Chief Revenue Officer and President of its Fintech Subsidiary, ALT5 Sigma

      LAS VEGAS, June 26, 2024 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a multidisciplinary organization with a focus on healthcare and fintech, is pleased to announce that it has appointed Mr. Vay Tham as its Chief Revenue Officer and President of ALT5 Sigma, Inc., its wholly-owned subsidiary. Mr. Tham brings extensive experience in capital markets, particularly in technology sectors, spanning over 25 years. His career includes roles in research, investment banking, and finance, notably and most recently as Managing Director and Head of Technology Investment Banking at PI Financial Corp. (Ventum Financial).

      6/26/24 7:30:00 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • JanOne Appoints Internationally Renowned Expert on Addiction Nicholas Goeders, Ph.D. to Scientific Advisory Board

      LAS VEGAS, June 15, 2021 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced the appointment of Nicholas E. Goeders, Ph.D. to its Scientific Advisory Board (SAB). Dr. Goeders is considered one of the world's leaders on the role of stress in drug addiction.  Tony Isaac, President and Chief Executive Officer of JanOne, commented, "JanOne's mission is to develop non-addictive medications to treat diseases that cause severe pain, thereby m

      6/15/21 10:15:00 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary

    $JAN
    Financials

    Live finance-specific insights

    See more
    • JanOne Announces Plan to Enhance Stockholder Value Through Strategic Realignment

      -The board has approved a strategic review of the biotech assets and ALT5 Sigma being the core focus going forward- -The company is intending a name and stock symbol change to reflect this decision- LAS VEGAS, July 10, 2024 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a multidisciplinary organization with a focus on fintech and healthcare, has announced plans to enhance stockholder value through a visionary strategic realignment, entailing a redeployment of biotech assets and a change of its name. The plan, unanimously approved by the company's board and following the May acquisi

      7/10/24 8:30:00 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • JanOne Inc. Completes Acquisition of Soin Therapeutics, LLC

      The acquisition of Soin provides JanOne with its second, late stage clinical stage asset LAS VEGAS, Jan. 10, 2023 /PRNewswire/ -- JanOne Inc. ("JanOne") (NASDAQ:JAN), a company that focuses on the development of drugs with non-addictive, pain-relieving properties, announced today that it has completed the acquisition of Soin Therapeutics, LLC and its product, a patent-pending, novel formulation of low-dose naltrexone. This all stock transaction has a value of $13M, with up to an additional $17M depending on revenues generated by the product, for a total value of up to $30M. The transaction includes restrictions on the maximum number of shares of preferred stock and common stock that can be i

      1/10/23 8:30:00 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • JanOne Inc. Acquires an Option for the Rights to a Worldwide, Exclusive License for a Novel Strategy for Treating Methamphetamine Use Disorder

      LAS VEGAS, Dec. 7, 2021 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company that focuses on the development of drugs with non-addictive, pain-relieving properties - in an effort to further reduce the drug addiction epidemic - today announced an option agreement for the rights to a novel strategy to reduce methamphetamine (meth) use by activating the Translocator Protein 18 kDa (TSPO).  The agreement with LSU Health Shreveport, along with other intellectual property relating to TSPO's role in treating meth use disorder (MUD), provides JanOne Inc. with an opportunity to identify new drugs to enhance TSPO activity, and by doing so, reducing craving for meth. This new strategy for treating MUD w

      12/7/21 9:00:00 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary

    $JAN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by JanOne Inc. (Amendment)

      SC 13G/A - JanOne Inc. (0000862861) (Subject)

      8/24/23 4:30:55 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • SEC Form SC 13G filed by JanOne Inc.

      SC 13G - JanOne Inc. (0000862861) (Subject)

      3/27/23 9:00:21 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • SEC Form SC 13G/A filed by JanOne Inc. (Amendment)

      SC 13G/A - JanOne Inc. (0000862861) (Subject)

      2/11/22 6:07:45 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary

    $JAN
    SEC Filings

    See more
    • JanOne Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - ALT5 Sigma Corp (0000862861) (Filer)

      7/17/24 2:55:12 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • JanOne Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - JanOne Inc. (0000862861) (Filer)

      6/21/24 5:22:48 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • SEC Form 424B5 filed by JanOne Inc.

      424B5 - JanOne Inc. (0000862861) (Filer)

      6/21/24 5:20:23 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary

    $JAN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Isaac Antonios was granted 125,787 shares, increasing direct ownership by 137% to 217,787 units

      4 - JanOne Inc. (0000862861) (Issuer)

      1/9/23 4:30:05 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • SEC Form 4: Johnson Virland A was granted 78,617 shares

      4 - JanOne Inc. (0000862861) (Issuer)

      1/9/23 4:20:58 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • SEC Form 4: Johnson Virland A sold $220,651 worth of Common Shares (32,933 units at $6.70), decreasing direct ownership by 100% to 0 units

      4 - JanOne Inc. (0000862861) (Issuer)

      5/26/21 4:02:12 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary